Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates

Pharmacology Biochemistry and Behavior

Volumn 86, Issue 4, 2007, Pages 766-773

  Foltin, Richard W ^a   Haney, Margaret ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Amphetamine; Baboon; Binge; Cannabinoid antagonist; Food intake; Motivation; Rimonabant; SR141716

Indexed keywords

DEXAMPHETAMINE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; BABOON; CARBOHYDRATE DIET; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; APPETITE DEPRESSANTS; BULIMIA; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; EATING; FEMALE; FOOD PREFERENCES; HUMANS; MALE; MODELS, ANIMAL; PAPIO CYNOCEPHALUS; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SATIETY RESPONSE; SEX CHARACTERISTICS;

ANIMALIA; PAPIO; PRIMATES;

EID: 34249661159     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.03.004     Document Type: Article

References (47)

1. Abel E.L. Cannabis: effects on hunger and thirst. Behav Biol 15 (1975) 255-281
2. 1 cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disorders. J Med Chem 49 (2006) 4008-4016
3. 1 ) receptors. Psychopharmacology (Berl) 132 (1997) 104-106
4. Collier G.H. Life in a closed economy: the ecology of learning and motivation (1983), John Wiley and Sons, Ltd.
5. Collier G.H. Satiety: an ecological perspective. Brain Res Bull 14 (1985) 693-700
6. Corwin R.L., and Buda-Levin A. Behavioral models of binge-type eating. Physiol Behav 82 (2004) 123-130
7. Corwin R.L., Wojnicki F.H., Fisher J.O., Dimitriou S.G., Rice H.B., and Young M.A. Limited access to a dietary fat option affects ingestive behavior but not body composition in male rats. Physiol Behav 65 (1998) 545-553
8. De Vry J., Schreiber R., Eckel G., and Jentzsch K.R. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur J Pharmacol 483 (2004) 55-63
9. Dimitriou S.G., Rice H.B., and Corwin R.L. Effects of limited access to a fat option on food intake and body composition in female rats. Int J Eat Disord 28 (2000) 436-445
10. Doucet E., St-Pierre S., Almeras N., and Tremblay A. Relation between appetite ratings before and after a standard meal and estimates of daily energy intake in obese and reduced obese individuals. Appetite 40 (2003) 137-143
11. Evans S.M., Haney M., and Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 159 (2002) 397-406
12. Foltin R.W. Effects of amphetamine, dexfenfluramine, diazepam, and dietary manipulations on responding reinforced by stimuli paired with food in nonhuman primates. Pharmacol Biochem Behav 77 (2004) 471-479
13. Foltin R.W. Effects of dietary and pharmacological manipulations on appetitive and consummatory aspects of feeding in non-human primates. Appetite 45 (2005) 110-120
14. Foltin R.W. Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates. Physiol Behav 87 (2006) 280-286
15. Foltin R.W. "Tasting and wasting" behavior in non-human primates: aberrant behavior or normal behavior in "times of plenty". Physiol Behav 89 (2006) 587-597
16. Foltin R.W., Fischman M.W., and Byrne M.F. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11 (1988) 1-14
17. Freedland C.S., Poston J.S., and Porrino L.J. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67 (2000) 265-270
18. Freedland C.S., Sharpe A.L., Samson H.H., and Porrino L.J. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res 25 (2001) 277-282
19. Gardner A., and Mallet P.E. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'. Eur J Pharmacol 530 (2006) 103-106
20. Gessa G.L., Orru A., Lai P., Maccioni P., Lecca R., Lobina C., et al. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. Psychopharmacology (Berl) 185 (2006) 248-254
21. Ginsburg B.C., and Lamb R.J. Cannabinoid effects on behaviors maintained by ethanol or food: a within-subjects comparison. Behav Pharmacol 17 (2006) 249-257
22. Higgs S., Williams C.M., and Kirkham T.C. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9) tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165 (2003) 370-377
23. 1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 19 (2005) 1567-1569
24. Justice A.J., and de Wit H. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 145 (1999) 67-75
25. Kirkham T.C. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16 (2005) 297-313
26. Kirkham T.C., Williams C.M., Fezza F., and Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136 (2002) 550-557
27. Luque C.A., and Rey J.A. The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 440 (2002) 119-128
28. 1 antagonists SR141716A and AM251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 14 (2003) 583-588
29. Mas M., Farre M., De La Torre R., Roset P.N., Ortuno J., Segura J., et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290 (1990) 136-145
30. Maldonado R., Valverde O., and Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29 (2006) 225-232
31. Matias I., Bisogno T., and Di Marzo V. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) 30 Suppl 1 (2006) S7-S12
32. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Kaufman M.J., Levin J.M., et al. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 21 (1999) 294-303
33. Padwal R.S., and Majumdar S.R. Drug treatments for obesity: orlistat, subutramine, and rimonabant. Lancet 369 (2007) 71-77
34. Perio A., Barnouin M.C., Poncelet M., and Soubrie P. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats. Behav Pharmacol 12 (2001) 641-645
35. 1 receptor deleted mice. Neurosci Lett 343 (2003) 216-218
36. Rowland N.E., Mukherjee M., and Robertson K. Effects of the cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 159 (2001) 111-116
37. 1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9 (1998) 179-181
38. Solinas M., and Goldberg S.R. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 30 (2005) 2035-2045
39. 1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology (Berl) 179 (2005) 452-460
40. Tseng A.H., and Craft R.M. Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 430 (2001) 41-47
41. 1(1) receptor mediation of cannabinoid behavioral effects in male and female rats. Psychopharmacology (Berl) 172 (2004) 25-30
42. Tseng A.H., Harding J.W., and Craft R.M. Pharmacokinetic factors in sex differences in delta 9-tetrahydrocannabinol-induced behavioral effects in rats. Behav Brain Res 154 (2004) 77-83
43. Van Gaal L.F., Rissanen A.M., Scheen A.J., Ziegler O., and Rossner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365 (2005) 1389-1397
44. Verty A.N., McGregor I.S., and Mallet P.E. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354 (2004) 217-220
45. 1 receptor agonism (CP-55940). Behav Pharmacol 16 (2005) 381-388
46. Wiley J.L., Lowe J.A., Balster R.L., and Martin B.R. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. J Pharmacol Exp Ther 275 (1995) 1-6
47. Winsauer P.J., Lambert P., and Moerschbaecher J.M. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol 10 (1999) 497-511